Next Article in Journal
One-Stop Dispensing: Hospital Costs and Patient Perspectives on Self-Management of Medication
Previous Article in Journal
Impact of Appointment-Based Medication Synchronization on Proportion of Days Covered for Chronic Medications
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessCommunication
Pharmacy 2018, 6(2), 45; https://doi.org/10.3390/pharmacy6020045

Co-Morbidities as Predictors of Airflow Limitation among Smokers in England

1
School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston Upon Thames KT1 2EE, UK
2
Croydon Health Services NHS Trust, Lennard Road, Croydon CR7 7YE, UK
*
Author to whom correspondence should be addressed.
Received: 2 May 2018 / Revised: 17 May 2018 / Accepted: 18 May 2018 / Published: 22 May 2018
Full-Text   |   PDF [501 KB, uploaded 22 May 2018]   |  

Abstract

The prevalence of co-morbidities among patients with Chronic Obstructive Pulmonary Disease (COPD) is well documented in the literature. Therefore, this pilot study aimed to identify whether co-morbidities screening would enhance COPD case-finding. Smoking patients were approached at Croydon University Hospital and two local community pharmacies (CPs). Their co-morbidities, respiratory symptoms, smoking pack-years and exercise capacity were collected. Airflow limitation was determined using handheld spirometry (COPD-6) device. The prevalence of airflow limitation was 42% (n = 21/50). The main identified predictors of airflow limitation were: co-morbidities (OR = 9, CI: 1.04–77.81, p = 0.025), respiratory symptoms (OR = 33.54, CI: 1.06–11.77, p = 0.039) and smoking history of ≥20 pack-years (OR = 3.94, CI: 1.13–13.64, p = 0.029). CPs were the main location for case-finding. This study demonstrated the need to screen for co-morbidities for COPD case-finding within CPs. View Full-Text
Keywords: Chronic Obstructive Pulmonary Disease (COPD), airflow limitation; co-morbidities; smoking; primary care Chronic Obstructive Pulmonary Disease (COPD), airflow limitation; co-morbidities; smoking; primary care
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kayyali, R.; Hassan, Y.; Hesso, I.; Siva, R. Co-Morbidities as Predictors of Airflow Limitation among Smokers in England. Pharmacy 2018, 6, 45.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top